MAR 28, 2020 7:21 AM PDT

FDA Approves 5-Minute Coronavirus Test

WRITTEN BY: Annie Lennon

In recent weeks, the US has struggled to supply enough tests to detect the coronavirus. Now, however, this may change thanks to the FDA’s approval of a rapid-testing device by Abbott Laboratories capable of telling if someone is infected with the virus in just five minutes. 

John Frels, vice president of research and development at Abbott Diagnostics, said, “This is really going to provide a tremendous opportunity for front-line caregivers, those having to diagnose a lot of infections, to close the gap with our testing...A clinic will be able to turn that result around quickly, while the patient is waiting.”

To take the test, medical practitioners must take a swab from a patient’s nose or the back of their throat. Then mixing the swab in a chemical solution to break the virus down and release its RNA for identification, it is then inserted into an ID Now system, a box weighing less than 7 pounds. This box then identifies and reads select sequences relevant to the coronavirus genome. Taking just five minutes to deliver positive results when the patient has a high viral load, a more thorough analysis to rule out the virus altogether takes up to 13 minutes. 

Abbott Diagnostics has said that they will be able to make 50,000 of these tests per day from April 1st, and that they can be used in practically any healthcare setting. Thus, the US government initially plans on delivering them to where they are most needed- particularly in hospital emergency rooms, urgent-care clinics and doctors’ offices. 

This news comes after the FDA’s approval of Abbott’s m2000 RealTime system, another diagnostic technique that, although takes longer to produce results, can be produced at a much faster rate: up to 1 million tests per week. The two systems taken together mean that Abbott will soon be able to create at least 5 million tests per month. 

Meanwhile, other companies have also been working hard to deliver diagnostic tools for the coronavirus. Henry Schein Inc, for example, announced the availability of its point-of care antibody test. Looking for evidence that a person’s immune system has already fought off the virus, the blood test delivers results within 15 minutes, although it can’t be used to detect current infections. 


Sources: Bloomberg, Chicago Business and CNN 

About the Author
  • Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
JUN 28, 2021
Microbiology
Small Clinical Trial Suggests New Edible Cholera Vaccine Is Safe
JUN 28, 2021
Small Clinical Trial Suggests New Edible Cholera Vaccine Is Safe
According to WHO there have been six cholera pandemics since the pathogen emerged from the Ganges river delta sometime i ...
JUL 21, 2021
Drug Discovery & Development
A diet rich in phytoestrogens can help combat inflammation in multiple sclerosis.
JUL 21, 2021
A diet rich in phytoestrogens can help combat inflammation in multiple sclerosis.
Close to one million people in the United States are living with multiple sclerosis (MS). MS is a chronic, neuroinflamma ...
AUG 01, 2021
Neuroscience
Keto-based Dietary Supplement Reduces Epileptic Seizures
AUG 01, 2021
Keto-based Dietary Supplement Reduces Epileptic Seizures
K.Vita, a dietary supplement, reduced seizures by 50% in adults and children with drug-resistant epilepsy in its first c ...
AUG 18, 2021
Neuroscience
Histamine Regulates Serotonin Levels in Depression
AUG 18, 2021
Histamine Regulates Serotonin Levels in Depression
Heightened histamine levels from inflammation inhibit the effects of the mood-regulating neurotransmitter serotonin in t ...
AUG 20, 2021
Drug Discovery & Development
Blood Pressure Drugs Boost Survival in Colorectal Cancer
AUG 20, 2021
Blood Pressure Drugs Boost Survival in Colorectal Cancer
Common drugs used to regulate blood pressure may improve survival rates among patients with colorectal cancer, also know ...
SEP 14, 2021
Health & Medicine
Graphene-Oxide Based Nanotechnology and Immunology-An Exciting Partnership
SEP 14, 2021
Graphene-Oxide Based Nanotechnology and Immunology-An Exciting Partnership
As treatments and infection control practices surrounding COVID-19 continue to evolve, nanotechnological solutions are b ...
Loading Comments...